Evaluation of the urinary kidney injury molecule-1 levels in patients with diabetic nephropathy

Clinical and Investigative Medicine

Volumn 37, Issue 6, 2014, Pages E377-E383

  Tekce, Buket Kin ^a   Tekce, Hikmet ^a   Aktas, Gulali ^a   Sit, Mustafa ^a  

^a ABANT IZZET BAYSAL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; GLYCOSYLATED HEMOGLOBIN; HAVCR1 PROTEIN, HUMAN; HEMOGLOBIN A1C PROTEIN, HUMAN; MEMBRANE PROTEIN; VIRUS RECEPTOR;

AGED; ALBUMINURIA; BLOOD; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; DIABETIC NEPHROPATHY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; MALE; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; URINE;

AGED; ALBUMINURIA; CREATININE; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; GLOMERULAR FILTRATION RATE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; RECEPTORS, VIRUS; RENAL INSUFFICIENCY, CHRONIC;

EID: 84939438127     PISSN: 0147958X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Rocco MV, Berns JS. KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update Foreword. Am J Kidney Dis. 2012 Nov;60(5):857-..
2. Eknoyan G, Levin NW. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification - Foreword. Am J Kidney Dis. 2002 Feb;39(2):S14-S266..
3. Kramer H, Molitch ME. Screening for kidney disease in adults with diabetes. Diabetes Care. 2005 Jul; 28(7): 1813-6.
4. Shemesh O, Golbetz H, Kriss JP, Myers BD. Limitations of Creatinine as a Filtration Marker in Glomerulopathic Patients. Kidney Int. 1985 Nov; 28(5): 830-8.
5. Rigalleau V, Lasseur C, Raffaitin C, Beauvieux MC, Barthe N, Chauveau P, et al. Normoalbuminuric renal-insufficient diabetic patients - A lower-risk group. Diabetes Care. 2007 Aug; 30(8): 2034-9.
6. Gilbert RE, Cooper ME. The tubulointerstitium in progressive diabetic kidney disease: More than an aftermath of glomerular injury? Kidney Int. 1999 Nov;56(5):1627-37..
7. Ichimura T, Bonventre JV, Bailly V, Wei H, Hession CA, Cate RL, et al. Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. J Biol Chem. 1998 Feb 13; 273(7): 4135-42.
8. Ichimura T, Hung CC, Yang SA, Stevens JL, Bonventre JV. Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injury. Am J Physiol-Renal. 2004 Mar 1; 286(3): F552-F63.
9. Han WK, Bailly V, Abichandani R, Thadhani R, Bonventre JV. Kidney Injury Molecule-1 (KIM-1): A novel biomarker for human renal proximal tubule injury. Kidney Int. 2002 Jul; 62(1): 237-44.
10. Kramer AB, van Timmeren MM, Schuurs TA, Vaidya VS, Bonventre JV, van Goor H, et al. Reduction of proteinuria in adriamycin-induced nephropathy is associated with reduction of renal kidney injury molecule (Kim-1) over time. Am J Physiol-Renal. 2009 May; 296(5): F1136-F45.
11. van Timmeren MM, van den Heuvel MC, Bailly V, Bakker SJL, van Goor H, Stegeman CA. Tubular kidney injury molecule-1 (KIM-1) in human renal disease. J Pathol. 2007 Jun; 212(2): 209-17.
12. van Timmeren MM, Bakker SJL, Vaidya VS, Bailly V, Schuurs TA, Damman J, et al. Tubular kidney injury molecule-1 in protein-overload nephropathy. Am J Physiol-Renal. 2006 Aug; 291(2): F456-F64.
13. Vaidya VS, V R, Ichimura T, Bobadilla NA, Bonventre JV. Urinary kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injury. Am J Physiol-Renal. 2006 Feb; 290(2): F517-F29.
14. Schultz CJ, Dalton RN, Neil HAW, Konopelska-Bahu T, Dunger DB, Study ORP. Markers of renal tubular dysfunction measured annually do not predict risk of microalbuminuria in the first few years after diagnosis of Type I diabetes. Diabetologia. 2001 Feb; 44(2): 224-9.
15. Peters HPE, Waanders F, Meijer E, van den Brand J, Steenbergen EJ, van Goor H, et al. High urinary excretion of kidney injury molecule-1 is an independent predictor of end-stage renal disease in patients with IgA nephropathy. Nephrol Dial Transpl. 2011 Nov; 26(11): 3581-8.
16. Devanand V, Chithrapavai SU. Correlation of 2 hours and 24 hours creatinine clearance in renal donors after unilateral nephrectomy. Journal of clinical and diagnostic research : JCDR. 2013 Oct; 7(10): 2119-21.
17. KDOQI. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. Am J Kidney Dis. 2007 Feb;49(2 Suppl 2):S12-154..
18. Fox CS LM, Leip EP, Meigs JB, Wilson PW, Levy D. Glycemic status and development of kidney disease: the Framingham Heart Study. Diabetes Care. 2005 (28):2436-40.
19. Brocco E, Fioretto P, Mauer M, Saller A, Carraro A, Frigato F, et al. Renal structure and function in non-insulin dependent diabetic patients with microalbuminuria. Kidney international Supplement. 1997 Dec;63:S40-4..
20. Nielsen SE, Schjoedt KJ, Astrup AS, Tarnow L, Lajer M, Hansen PR, et al. Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Kidney Injury Molecule 1 (KIM1) in patients with diabetic nephropathy: a cross-sectional study and the effects of lisinopril. Diabetic Med. 2010 Oct; 27(10): 1144-50.
21. Pantelis A. Sarafidis LMR. Insulin Resistance, Hyperinsulinemia, and Renal Injury: Mechanisms and Implications. Am J Nephrol. 2006 (26):232-44.
22. Axel C. Carlsson MC, Ulf Riserus, Anders Larsson, Johanna Helmersson-Karlqvist, Lars Lind, Johan Arnlov. Kidney injury molecule (KIM)-1 is associated with insulin resistance: Results from two community-based studies of elderly individuals. Diabetes Research and Clinical Practice. 2014 (103):516-21.
23. Humphreys BD, Xu FF, Sabbisetti V, Grgic I, Naini SM, Wang NN, et al. Chronic epithelial kidney injury molecule-1 expression causes murine kidney fibrosis. J Clin Invest. 2013 Sep; 123(9): 4023-35.
24. Moresco RN, Sangoi MB, De Carvalho JAM, Tatsch E, Bochi GV. Diabetic nephropathy: Traditional to proteomic markers. Clin Chim Acta. 2013 Jun 5;421:17-30..
25. Conway BR, Manoharan D, Manoharan D, Jenks S, Dear JW, McLachlan S, et al. Measuring urinary tubular biomarkers in type 2 diabetes does not add prognostic value beyond established risk factors. Kidney Int. 2012 Oct; 82(7): 812-8.